Evidence map›Paper›PMID 34829944›Full record

ArticleBiomedicines2021

Oxidized LDL Increase the Proinflammatory Profile of Human Visceral Adipocytes Produced by Hypoxia.

Concepción Santiago-Fernández, Flores Martín-Reyes, Monica Tome, Carolina Gutierrez-Repiso, Diego Fernandez-Garcia, Luis Ocaña-Wilhelmi, Jose Rivas-Becerra, Franz Tatzber, Edith Pursch, Francisco J Tinahones and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Concepción Santiago-FernándezUnidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0003-4439-6863
Flores Martín-ReyesUnidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0002-3633-8367
Monica TomeUnidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain.
Carolina Gutierrez-RepisoUnidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0002-5842-8873
Diego Fernandez-GarciaUnidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Luis Ocaña-WilhelmiUnidad de Gestión Clínica de Cirugía General y Digestiva, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Jose Rivas-BecerraUnidad de Gestión Clínica de Cirugía General, Digestiva y Trasplantes, Hospital Regional Universitario, 29010 Málaga, Spain.
Franz TatzberOtto Loewi Research Center, Division of Immunology and Pathophysiology, Medical University of Graz, 8010 Graz, Austria.
Edith PurschInstitute of Biochemical Engineering, University of Applied Sciences Technikum-Wien, 1200 Vienna, Austria.
Francisco J TinahonesUnidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Eduardo García-FuentesUnidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0002-3491-2724
Lourdes Garrido-SánchezUnidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA)/Universidad de Málaga, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Instituto de Salud Carlos III · ESInstituto de Investigación Biomédica de Málaga · ESHospital Regional Universitario de Málaga · ESHospital Clínico Universitario Virgen de la Victoria · ESMedical University of Graz · ATUniversity of Applied Sciences Technikum Wien · AT

Funding

Instituto de Salud Carlos III CP13/00188
6 · The paper itself

Abstract

backgroundLittle is known about the effects of hypoxia on scavenger receptors (SRs) levels in adipocytes. We analyzed the effect of morbid obesity and hypoxia on SRs and inflammation markers in human visceral adipocytes and whether ox-LDL modify the inflammatory profile produced by hypoxia.

methodsWe studied in 17 non-obese and 20 subjects with morbid obesity (MO) the mRNA expression of HIF-1α, SRs (LOX-1, MSR1, CL-P1 and CXCL16), IL6 and TNFα in visceral adipocytes and the effect of hypoxia with or without ox-LDL on visceral in vitro-differentiated adipocytes (VDA).

resultsHIF-1α, TNFα, IL6, LOX-1, MSR1 and CXCL16 expression in adipocytes was increased in MO when compared with those in non-obese subjects (

conclusionsMorbid obesity and hypoxia increased SRs and inflammatory markers in visceral adipocytes. In a hypoxic state, ox-LDL increased the proinflammatory response of visceral adipocytes to hypoxia.

Indexed as

adipocyteshypoxiamorbid obesityoxidized LDLscavenger receptors

Identifiers

PMID34829944
PMCPMC8615639
OpenAlexW3217806680

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.